Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter Learning 500 Chinese characters in 30 days is possible. Abstract • About

Ischemic Heart Disease

Free Subscription 06.04.2026 1 Am Heart J 9 Am J Cardiol 1 Am J Med 4 Angiology 1 Arterioscler Thromb Vasc Biol 2 BMJ 1 Can J Cardiol 1 Cardiovasc Res 21 Catheter Cardiovasc Interv 1 Chest 1 Circ Cardiovasc Interv 1 Circ Genom Precis Med 10 Circulation 1 Clin Cardiol 1 Int J Cardiol 3 J Am Coll Cardiol 2 J Cardiovasc Pharmacol 1 J Clin Invest 1 J Thorac Cardiovasc Surg 1 J Thromb Haemost 6 JAMA 4 Lancet 1 Mayo Clin Proc 1 Mol Cell Biochem 6 N Engl J Med 3 PLoS One 1 Prog Cardiovasc Dis

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am Heart J

1. JIN IT, Lee SH, Yun KH, Kim W, et al
   Optimal antiplatelet strategy in patients with advanced chronic kidney disease undergoing drug-eluting stent implantation: Design and rationale of the randomized ADAPT-CKD trial.
   Am Heart J. 2026 Apr 1:107437. doi: 10.1016/j.ahj.2026.107437.
   PubMed         Abstract available
   
   

   
   Am J Cardiol

2. PAVANI G, Marco P, Cerrato E, Zecchino S, et al
   The Unholy Trinity: A Hybrid PCI Approach for Left Main Pseudoaneurysm, In-Stent Restenosis, and Acute Myocardial Infarction.
   Am J Cardiol. 2026 Mar 27:S0002-9149(26)00181.
   PubMed         Abstract available
   
   
3. EDENS M, Oliva A, Sartori S, Muro FMD, et al
   Clinical Differences and Disparities Among Men and Women with Acute Myocardial Infarction-Related Cardiogenic Shock Undergoing Percutaneous Coronary Intervention.
   Am J Cardiol. 2026 Mar 27:S0002-9149(26)00193.
   PubMed         Abstract available
   
   
4. LEONE PP, Gitto M, Regazzoli D, Calamita G, et al
   Sirolimus-Coated Balloon with Phospholipid Nanocarriers or Biodegradable Polymer Microspheres for Treatment of Coronary Artery Disease.
   Am J Cardiol. 2026 Mar 29:S0002-9149(26)00180.
   PubMed         Abstract available
   
   
5. REMPAKOS A, Strepkos D, Alexandrou M, Mutlu D, et al
   Impact of adherence to the global algorithm for initial crossing strategy selection in chronic total occlusion percutaneous coronary intervention.
   Am J Cardiol. 2026 Mar 26:S0002-9149(26)00185.
   PubMed         Abstract available
   
   
6. CELESKI M, Golino M, Muro FMD, Martino G, et al
   Beyond Percutaneous Coronary Intervention - Targeted Molecular Therapies for the Next Era of Coronary Care.
   Am J Cardiol. 2026 Mar 26:S0002-9149(26)00201.
   PubMed         Abstract available
   
   
7. QUEVEDO-CANDELA F, Cieza T, Ruhl A, Nolte C, et al
   Drug-Coated Balloons Versus Drug-Eluting Stents for Side Branch Lesions in Coronary Bifurcations: An Updated Comparative Meta-Analysis.
   Am J Cardiol. 2026 Mar 26:S0002-9149(26)00191.
   PubMed         Abstract available
   
   
8. ADREJIYA P, Bhanushali A, Mehta K, Amin M, et al
   Breast arterial calcification on mammography and cardiovascular outcomes in women: a meta-analysis.
   Am J Cardiol. 2026 Mar 25:S0002-9149(26)00190.
   PubMed         Abstract available
   
   
9. SINGH J, Jatana N
   Cardiovascular Disease and Sudden Cardiac Arrest in Young Individuals: An Evolving Challenge.
   Am J Cardiol. 2026 Mar 25:S0002-9149(26)00188.
   PubMed         Abstract available
   
   
10. GURGOGLIONE FL, Frazzetto M, Gitto M, Leone PP, et al
    Drug-Coated Balloon Versus Drug-Eluting Stent for Coronary Revascularization in Patients with Chronic Kidney Disease: A Real-World Propensity-Matched Study.
    Am J Cardiol. 2026 Mar 25:S0002-9149(26)00197.
    PubMed         Abstract available
    
    

    
    Am J Med

11. MAGEN E, Merzon E, Magen I, Yakov A, et al
    Chronic Idiopathic Eosinopenia and Long-Term Cardiovascular Outcomes: A Population-Based Cohort Study.
    Am J Med. 2026 Apr 1:S0002-9343(26)00261-5. doi: 10.1016/j.amjmed.2026.
    PubMed         Abstract available
    
    

    
    Angiology

12. ALPASLAN E
    Letter: NLRC5 and NF-kappaB Signaling: Implications for Atherosclerotic Plaque Formation in Acute Coronary Syndromes.
    Angiology. 2026 Mar 28:33197261435402. doi: 10.1177/00033197261435402.
    PubMed        
    
    
13. KARAYAKALI M, Kadi H, Karaman K, Celik A, et al
    Response to the Letter Regarding "Relationship Between the Severity of Coronary Artery Disease and Renal Function".
    Angiology. 2026 Mar 28:33197261435386. doi: 10.1177/00033197261435386.
    PubMed        
    
    
14. DU Z, Cao C, Lv X, Hou Y, et al
    The Association Between Depression and Advanced Stages of Cardiovascular-Kidney-Metabolic Syndrome.
    Angiology. 2026 Apr 1:33197261434136. doi: 10.1177/00033197261434136.
    PubMed         Abstract available
    
    
15. DOGAN O, Barman HA, Ebeoglu AO, Ebeoglu SI, et al
    Letter: Remnant Cholesterol as a Predictor of No-Reflow Phenomenon in Patients With ST-Segment Elevation Myocardial Infarction.
    Angiology. 2026 Apr 3:33197261435380. doi: 10.1177/00033197261435380.
    PubMed        
    
    

    
    Arterioscler Thromb Vasc Biol

16. EL-SABAWI B, Huang X, Lin P, Anwar MY, et al
    Proteogenomic Analysis of Coronary Artery Calcification in Human Populations.
    Arterioscler Thromb Vasc Biol. 2026 Apr 2. doi: 10.1161/ATVBAHA.125.324171.
    PubMed         Abstract available
    
    

    
    BMJ

17. 
    RETRACTION: Prevention of acute myocardial infarction induced heart failure by intracoronary infusion of mesenchymal stem cells: phase 3 randomised clinical trial (PREVENT-TAHA8).
    BMJ. 2026;392:s579.
    PubMed        
    
    
18. 
    CORRECTION: Prevention of acute myocardial infarction induced heart failure by intracoronary infusion of mesenchymal stem cells: phase 3 randomised clinical trial (PREVENT-TAHA8).
    BMJ. 2026;392:s574.
    PubMed        
    
    

    
    Can J Cardiol

19. FIORI E, Dierckx R, Dauw J, Heggermont W, et al
    Right Ventricular Failure Secondary to Delayed Ventricular Septal Rupture After Myocardial Infarction in a Left Ventricular Assist Device Recipient.
    Can J Cardiol. 2026 Mar 27:S0828-282X(26)00285.
    PubMed        
    
    

    
    Cardiovasc Res

20. CLELAND JGF, Hurdus B, Gale CP
    Withholding beta-blockers after myocardial infarction: reasons to be cautious.
    Cardiovasc Res. 2026 Apr 2:cvag046. doi: 10.1093.
    PubMed        
    
    

    
    Catheter Cardiovasc Interv

21. BIRGUN A, Celik MC, Yetim M, Kalcik M, et al
    Coronary Computed Tomography Angiography Identifying a Single Coronary Artery With a Critical Left-Main-Equivalent Stenosis Treated by Elective PCI.
    Catheter Cardiovasc Interv. 2026 Jan 29. doi: 10.1002/ccd.70492.
    PubMed         Abstract available
    
    
22. FORD TJ, Parkinson M, Hanratty C, Walsh S, et al
    The "Skipping Rope" Technique: A Novel Strategy for Distal Burr Entrapment During Rotational Atherectomy.
    Catheter Cardiovasc Interv. 2026;107:1389-1392.
    PubMed         Abstract available
    
    
23. YANG J, Fang Y, Yan Y, Liu Z, et al
    Feasibility and Safety of the ETcath200 Robotic PCI System for Complex Coronary Lesions: A Prospective Single-Center Study.
    Catheter Cardiovasc Interv. 2026;107:1393-1402.
    PubMed         Abstract available
    
    
24. MORI H, Kurita T, Takasaki A, Dohi K, et al
    Successful Percutaneous Rescue of an Entrapped Rotablator Burr With a Previously Implanted Stent: A Rare and Challenging Case of En Bloc Extraction of Stent, Burr, and Guidewire.
    Catheter Cardiovasc Interv. 2026;107:1384-1388.
    PubMed         Abstract available
    
    
25. COLAIORI I, Paolucci L, Mangiacapra F, Barbato E, et al
    Vessel-Oriented Analysis on the Relationship Between Quantitative-Flow Ratio and Mortality in Patients With Severe Aortic Stenosis and Intermediate Coronary Lesions.
    Catheter Cardiovasc Interv. 2026 Jan 29. doi: 10.1002/ccd.70491.
    PubMed         Abstract available
    
    
26. HIRAI K, Kawasaki T, Serikawa S, Yamamoto T, et al
    Determinants of Left Ventricular Ejection Fraction Improvement After Successful Percutaneous Coronary Intervention for Chronic Total Occlusion: A Study Using Myocardial Perfusion Imaging.
    Catheter Cardiovasc Interv. 2026 Jan 19. doi: 10.1002/ccd.70484.
    PubMed         Abstract available
    
    
27. XIA Q, Yang S, Pan L, Wang X, et al
    OCT-Derived Virtual Fractional Flow Reserve Associated With 1-Year Outcomes After PCI in ACS Patients.
    Catheter Cardiovasc Interv. 2026;107:1324-1332.
    PubMed         Abstract available
    
    
28. ZUIN M, Marchese G, Hiso E, Bertolini A, et al
    A Computational Fluid Dynamics-Based Risk Score Predicting 3-Year Cardiovascular Outcomes After Complex Left Main Bifurcation PCI: The SCORE-CLM.
    Catheter Cardiovasc Interv. 2026;107:1340-1349.
    PubMed         Abstract available
    
    
29. COLOMBO A, Carbonaro D, Zhang M, Chiastra C, et al
    Mechanistic Insights Into How Rewiring and Bifurcation Angle Affect DK-Crush Stent Deployment.
    Catheter Cardiovasc Interv. 2026;107:1314-1323.
    PubMed         Abstract available
    
    
30. ELHAKIM A, Elhakim M, Saad M, Bisht O, et al
    Does Sirolimus-Eluting Resorbable Magnesium Scaffold Plays a Role in Iatrogenic Flow-Limiting Coronary Artery Dissection?
    Catheter Cardiovasc Interv. 2026;107:1312-1313.
    PubMed         Abstract available
    
    
31. PARK I, Watkins M, Dinh D, Brennan A, et al
    Clinical Outcomes in Young Patients Undergoing Percutaneous Coronary Intervention.
    Catheter Cardiovasc Interv. 2026 Jan 16. doi: 10.1002/ccd.70434.
    PubMed         Abstract available
    
    
32. ASADI A, Jolfayi AG, Karimzadeh R, Babaei M, et al
    Low-Power Lasers Therapy Induced Mir-143 Upregulation: A Novel Biomarker and Therapeutic Strategy for Restenosis.
    Catheter Cardiovasc Interv. 2026;107:1514-1524.
    PubMed         Abstract available
    
    
33. KAYE G, Jeyaprakash P, Abdrazak M, Rao R, et al
    Dynamic SCAI Shock Grade Is Independently Associated With Circulatory Death After Resuscitation of Out-of-Hospital Cardiac Arrest.
    Catheter Cardiovasc Interv. 2026;107:1529-1536.
    PubMed         Abstract available
    
    
34. ITELMAN E, Rotholz A, Bental T, Lerman TT, et al
    Procedural and Prognostic Implications of Guide Extension Catheter Use During Percutaneous Coronary Intervention: A Retrospective Cohort Study.
    Catheter Cardiovasc Interv. 2026 Feb 8. doi: 10.1002/ccd.70477.
    PubMed         Abstract available
    
    
35. PRASAD AK, Prasad AM, Sardar S, Gawalkar AA, et al
    Complication Secondary to Coronary Guidewire Twisting Method to Retrieve Dislodged Stent.
    Catheter Cardiovasc Interv. 2026;107:1428-1431.
    PubMed         Abstract available
    
    
36. KLADOU E, Strepkos D, Alexandrou M, Carvalho PEP, et al
    HydroDynamic Recanalization for Chronic Total Occlusion Percutaneous Coronary Intervention: Insights From the PROGRESS-CTO Registry.
    Catheter Cardiovasc Interv. 2026 Feb 8. doi: 10.1002/ccd.70502.
    PubMed         Abstract available
    
    
37. VERDOIA M, Viola O, Rognoni A
    Dealing With Calcium in STEMI: A Unique Case of Intracoronary Fracture and Rescue of a Guide Catheter Extension.
    Catheter Cardiovasc Interv. 2026;107:1525-1528.
    PubMed         Abstract available
    
    
38. BIANCHINI E, Lunardi M, Casamassima F, Bianchini F, et al
    Clinical Impact of Angiographic Complications Occurring During Percutaneous Coronary Interventions.
    Catheter Cardiovasc Interv. 2026 Feb 10. doi: 10.1002/ccd.70515.
    PubMed         Abstract available
    
    
39. DENG B, Liu W
    Thrombolysis for De Winter Syndrome When Percutaneous Coronary Intervention is Delayed: A Critical Review.
    Catheter Cardiovasc Interv. 2026 Feb 9. doi: 10.1002/ccd.70501.
    PubMed         Abstract available
    
    
40. KAWAMURA A, Okayama K, Nohara H, Nakano T, et al
    Difference Between Low-Speed and High-Speed Rotational Atherectomy Using Two Types of Guidewires.
    Catheter Cardiovasc Interv. 2026;107:1494-1502.
    PubMed         Abstract available
    
    
41. LIU Y, Liu X, Sun D, Gu R, et al
    Aspirin Combined With Ticagrelor or Clopidogrel in STEMI Patients With Diabetes Mellitus and Poor Glycemic Control Undergoing Primary PCI: A Multicenter Retrospective Cohort Study.
    Catheter Cardiovasc Interv. 2026;107:1562-1572.
    PubMed         Abstract available
    
    

    
    Chest

42. LIN CY, Zhong BK, Chou YT, Kuo CW, et al
    Eosinophilic Versus Non-Eosinophilic Acute Exacerbations of COPD and Subsequent Cardiovascular Event.
    Chest. 2026 Apr 1:S0012-3692(26)00432-0. doi: 10.1016/j.chest.2026.
    PubMed         Abstract available
    
    

    
    Circ Cardiovasc Interv

43. SUZUKI T, Asano T, Shinozaki T, Kohsaka S, et al
    Prognostic Implications of Bleeding and Ischemic Complications in Acute Myocardial Infarction-Related Cardiogenic Shock Managed With Microaxial Flow Pump.
    Circ Cardiovasc Interv. 2026 Mar 29:e015676.
    PubMed         Abstract available
    
    

    
    Circ Genom Precis Med

44. GUERRATY MA, Verma SS, Ko YA, McQuillan MA, et al
    Friend of GATA2 Variant Ser657Gly Is Associated With Coronary Microvascular Disease.
    Circ Genom Precis Med. 2026 Apr 1:e005342. doi: 10.1161/CIRCGEN.125.005342.
    PubMed         Abstract available
    
    

    
    Circulation

45. LI L
    Myocardial Infarction, Precision-Engineered T Regulatory Cells to the Rescue.
    Circulation. 2026;153:998-1000.
    PubMed        
    
    
46. ZHANG M, Qin Y, Zhou T, Liu M, et al
    Engineered Regulatory T Lymphocytes Promote Infarcted Heart Repair.
    Circulation. 2026;153:983-997.
    PubMed         Abstract available
    
    
47. HOJBJERG LASSEN MC, Ostrominski JW, Claggett BL, Ndumele CE, et al
    Cardiovascular-Kidney-Metabolic Syndrome Stages, Echocardiographic Characteristics, and Heart Failure Risk: The Atherosclerosis Risk in Communities Study.
    Circulation. 2026 Apr 1. doi: 10.1161/CIRCULATIONAHA.125.077894.
    PubMed         Abstract available
    
    
48. LICHTENSTEIN AH, Khera A, Anderson CAM, Appel LJ, et al
    2026 Dietary Guidance to Improve Cardiovascular Health: A Scientific Statement From the American Heart Association.
    Circulation. 2026 Mar 31. doi: 10.1161/CIR.0000000000001435.
    PubMed         Abstract available
    
    
49. PIANO MR, Marcus GM, Aycock DM, Buckman J, et al
    Correction to: Alcohol Use and Cardiovascular Disease: A Scientific Statement From the American Heart Association.
    Circulation. 2026;153:e1106.
    PubMed        
    
    
50. BELLAVIA A, Murphy SA
    Competing Risks in Cardiovascular Research: A Practical Perspective.
    Circulation. 2026;153:945-947.
    PubMed        
    
    
51. HUNDEMER GL, Vaidya A
    Response by Hundemer and Vaidya to Letter Regarding Article, "Subclinical Primary Aldosteronism and Major Adverse Cardiovascular Events: A Longitudinal Population-Based Cohort Study".
    Circulation. 2026;153:e1053-e1054.
    PubMed        
    
    
52. XU J, Sun Y
    Letter by Xu and Sun Regarding Article, "Subclinical Primary Aldosteronism and Major Adverse Cardiovascular Events: A Longitudinal Population-Based Cohort Study".
    Circulation. 2026;153:e1052.
    PubMed        
    
    
53. VEMULAPALLI S, Pena Guerra K, Wojdyla D, Jones WS, et al
    Adaptive AI for Cardiovascular Event Adjudication: Cardiovascular Event Adjudication Across Different Definitions in the ODYSSEY OUTCOMES and EUCLID Trials.
    Circulation. 2026 Mar 30. doi: 10.1161/CIRCULATIONAHA.126.080072.
    PubMed         Abstract available
    
    
54. MARSTON NA, Bergmark BA, Prohaska TA, Moura FA, et al
    Effect of APOC3 Inhibition with Olezarsen on Coronary Atherosclerosis: Essence-TIMI 73b Imaging Study.
    Circulation. 2026 Mar 30. doi: 10.1161/CIRCULATIONAHA.126.080012.
    PubMed         Abstract available
    
    

    
    Clin Cardiol

55. CECCHI E, Granchietti AG, Mazzotta R, Garofalo M, et al
    Stent Thrombosis: A Narrative Review From Pathophysiology to Therapy.
    Clin Cardiol. 2026;49:e70286.
    PubMed         Abstract available
    
    

    
    Int J Cardiol

56. ANGIOLILLO DJ, Erlinge D, Gale CP, Gorog DA, et al
    Real-world adoption of the 2023 European Society of Cardiology guidelines regarding antiplatelet strategies in acute coronary syndromes: Insights from the European READAPT-2 survey.
    Int J Cardiol. 2026;453:134288.
    PubMed         Abstract available
    
    

    
    J Am Coll Cardiol

57. AL-AZZAWY SM, De Bacquer D, McEvoy JW, Adamska A, et al
    Chronic Kidney Disease Screening in Patients With Coronary Heart Disease: The Multinational INTERASPIRE Study.
    J Am Coll Cardiol. 2026 Mar 19:S0735-1097(26)00327.
    PubMed         Abstract available
    
    
58. WOLHUTER K, Nedkoff L, Miller MR, Kovacic JC, et al
    Breathing Fire: Cumulative Wildfire Smoke Exposure as a Cardiovascular Risk Factor.
    J Am Coll Cardiol. 2026 Mar 24:S0735-1097(26)05637.
    PubMed        
    
    
59. GAO X, Kan J, Chen Y, Chen X, et al
    IVUS or Angiography Guidance for Percutaneous Coronary Intervention in Complex Coronary Bifurcation Lesions: The DKCRUSH VIII Randomized Clinical Trial.
    J Am Coll Cardiol. 2026 Mar 30:S0735-1097(26)05227.
    PubMed         Abstract available
    
    

    
    J Cardiovasc Pharmacol

60. KHAN M, Janjua MAH, Akhtar SMM, Al-Qaraghuli A, et al
    Efficacy and Safety of Aspirin-free versus Aspirin-based Strategies in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis.
    J Cardiovasc Pharmacol. 2026;87:209-218.
    PubMed         Abstract available
    
    
61. AKSOY F, Savran M, Uysal D, Bagci A, et al
    Cannabidiol Protects the Heart From Ischemia-Reperfusion Injury Through SIRT-1/PGC-1alpha Activation and Nuclear Factor Kappa B Modulation: Experimental Insights.
    J Cardiovasc Pharmacol. 2026;87:270-282.
    PubMed         Abstract available
    
    

    
    J Clin Invest

62. LEE SJ, Lee CK, Kang S, Park I, et al
    Corrigendum to Angiopoietin-2 exacerbates cardiac hypoxia and inflammation after myocardial infarction.
    J Clin Invest. 2026;136:e205881.
    PubMed        
    
    

    
    J Thorac Cardiovasc Surg

63. VOLK L, Cornwell L, Pajaro O, Kolodziejski P, et al
    Arterial graft choice and outcomes within the Veterans Administration: A 20-year review of 47,525 patients.
    J Thorac Cardiovasc Surg. 2026;171:936-943.
    PubMed         Abstract available
    
    

    
    J Thromb Haemost

64. LI J, Gong Z, Wang S, Gu J, et al
    The Dual Role of P2RY12: Impact of Polymorphism and Expression on Ischemic Events and Bleeding in Patients with ST-Segment Elevation Myocardial Infarction Receiving Antithrombotic Therapy.
    J Thromb Haemost. 2026 Mar 26:S1538-7836(26)00206.
    PubMed         Abstract available
    
    

    
    JAMA

65. LANPHEAR BP
    Reframing the Coronary Heart Disease Epidemic-The Role of Lead Exposure.
    JAMA. 2026 Mar 30. doi: 10.1001/jama.2026.3041.
    PubMed        
    
    
66. WINCHESTER DE, Mehta JJ, Alexander JT
    Perioperative Cardiovascular Medication Management for Noncardiac Surgery.
    JAMA. 2026 Mar 31. doi: 10.1001/jama.2026.0067.
    PubMed        
    
    
67. STANAWAY JD, Spearman S, DeCleene NK, Garcia V, et al
    Lead-Attributable Cardiovascular Disease Burden: Global Burden of Disease Study 2023.
    JAMA. 2026 Mar 30:e262197. doi: 10.1001/jama.2026.2197.
    PubMed         Abstract available
    
    
68. VOHRA AS, Alexander JT, Shah AP
    Management of Acute Coronary Syndrome.
    JAMA. 2026 Mar 30. doi: 10.1001/jama.2026.1214.
    PubMed        
    
    
69. 
    Evolocumab to Reduce First Major Cardiovascular Events in Patients Without Known Significant Atherosclerosis and With Diabetes: Research Summary.
    JAMA. 2026 Mar 28:e263429. doi: 10.1001/jama.2026.3429.
    PubMed        
    
    
70. MARSTON NA, Bohula EA, Bhatia AK, De Ferrari GM, et al
    Evolocumab to Reduce First Major Cardiovascular Events in Patients Without Known Significant Atherosclerosis and With Diabetes: Results From the VESALIUS-CV Trial.
    JAMA. 2026 Mar 28:e263277. doi: 10.1001/jama.2026.3277.
    PubMed         Abstract available
    
    

    
    Lancet

71. CHIARITO M, Tartaglia F
    Moving beyond aspirin after percutaneous coronary intervention: 10-year results from the HOST-EXAM trial.
    Lancet. 2026 Mar 29:S0140-6736(26)00562-3. doi: 10.1016/S0140-6736(26)00562.
    PubMed        
    
    
72. GAROT P, Akodad M
    Coronary revascularisation before TAVI.
    Lancet. 2026 Mar 29:S0140-6736(26)00597-0. doi: 10.1016/S0140-6736(26)00597.
    PubMed        
    
    
73. DELEWI R, Aarts HM, Broeze GM, Hemelrijk KI, et al
    Deferral of percutaneous coronary intervention in patients undergoing transcatheter aortic valve implantation (PRO-TAVI): an investigator-initiated, multicentre, open-label, non-inferiority, randomised controlled trial.
    Lancet. 2026 Mar 29:S0140-6736(26)00308-9. doi: 10.1016/S0140-6736(26)00308.
    PubMed         Abstract available
    
    
74. KANG J, Park S, Yang HM, Shin ES, et al
    Aspirin versus clopidogrel for chronic maintenance monotherapy after percutaneous coronary intervention: 10-year follow-up of the HOST-EXAM trial.
    Lancet. 2026 Mar 29:S0140-6736(26)00422-8. doi: 10.1016/S0140-6736(26)00422.
    PubMed         Abstract available
    
    

    
    Mayo Clin Proc

75. JAIN H, Jain J, Soni K, Agrawal SP, et al
    Beta Blockers After Acute Myocardial Infarction Without Left Ventricular Systolic Dysfunction: A Meta-Analysis of Randomized Controlled Trials.
    Mayo Clin Proc. 2026 Mar 28:S0025-6196(26)18387.
    PubMed        
    
    

    
    Mol Cell Biochem

76. ZHANG X, Liu J, He C, Wang Y, et al
    From copper transport to cuproptosis: emerging therapeutic targets in cardiovascular disease.
    Mol Cell Biochem. 2026 Apr 2. doi: 10.1007/s11010-026-05527.
    PubMed        
    
    

    
    N Engl J Med

77. TESTA L, De la Torre Hernandez JM, De Maria GL, Jones DA, et al
    IVUS-Guided versus Angiography-Guided PCI in Unprotected Left Main Coronary Disease.
    N Engl J Med. 2026 Mar 30. doi: 10.1056/NEJMoa2600440.
    PubMed         Abstract available
    
    
78. CHOI KH, Kang D, Kim W, Doh JH, et al
    Discontinuation of Beta-Blocker Therapy after Myocardial Infarction.
    N Engl J Med. 2026;394:1302-1312.
    PubMed         Abstract available
    
    
79. WELT F
    Seeing the Left Main Coronary Artery Clearly - Is IVUS Always Necessary?
    N Engl J Med. 2026 Mar 30. doi: 10.1056/NEJMe2602959.
    PubMed        
    
    
80. DAEMEN J, van der Eijk JA, Barbierato M, Byrne RA, et al
    Angiography-Based Physiology to Guide Coronary Revascularization.
    N Engl J Med. 2026 Mar 29. doi: 10.1056/NEJMoa2601841.
    PubMed         Abstract available
    
    
81. PERERA D, Ryan M, Ezad SM, Khan SQ, et al
    Left Ventricular Unloading in High-Risk Percutaneous Coronary Intervention.
    N Engl J Med. 2026 Mar 29. doi: 10.1056/NEJMoa2515704.
    PubMed         Abstract available
    
    
82. LEE YJ, Lee SJ, Kim JW, Lee SH, et al
    Intensive LDL Cholesterol Targeting in Atherosclerotic Cardiovascular Disease.
    N Engl J Med. 2026 Mar 28. doi: 10.1056/NEJMoa2600283.
    PubMed         Abstract available
    
    

    
    PLoS One

83. RAMOS TMB, Monteiro Junior JGM, Furtado VC, de Paula MLS, et al
    Hematological parameters as predictors of complex angiographic coronary lesions in patients with acute myocardial infarction.
    PLoS One. 2026;21:e0345569.
    PubMed         Abstract available
    
    
84. QUACH HT, Nguyen ATK, Dinh BQ, Nguyen TM, et al
    Favorable association between early initiation of sodium-glucose cotransporter-2 inhibitors and in-hospital prognosis in acute myocardial infarction.
    PLoS One. 2026;21:e0345315.
    PubMed         Abstract available
    
    
85. PLASTO TM, Tofler GH, Buckley T
    Football (Soccer) refereeing and cardiovascular health: A scoping review.
    PLoS One. 2026;21:e0346360.
    PubMed         Abstract available
    
    

    
    Prog Cardiovasc Dis

86. KHAN S, Karim S, Somers VK
    Beyond duration: The emerging role of sleep architecture in cardiovascular risk prediction.
    Prog Cardiovasc Dis. 2026 Mar 26:S0033-0620(26)00027.
    PubMed        
    
    

Thank you for your interest in scientific medicine.

AMEDEO Ischemic Heart Disease is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum